Market Cap | 2.24M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | 943.68k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 17.00% |
Sales | 5.27M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 29.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -14.00% |
Recommedations | - | Quick Ratio | 0.04 | Shares Outstanding | 7.73B | 52W Low Chg | 100.00% |
Insider Own | 54.58% | ROA | -8.93% | Shares Float | 3.61B | Beta | 2.53 |
Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00060 |
Gross Margin | 45.43% | Profit Margin | 17.91% | Avg. Volume | 9,325,216 | Target Price | - |
Oper. Margin | -18.62% | Earnings Date | Nov 18 | Volume | 310,000 | Change | 9.09% |
Ethema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. Ethema Health Corporation is based in West Palm Beach, Florida.